Exor: Fiat Crisis to Ferrari Glory
What this covers
Krishna and Zack treat Exor first as a business history and then as a valuation puzzle. The story starts in 2003-04, when John Elkann became the family's sole representative at Fiat around age 27. The company was struggling and had gone through four CEOs in three years. His grandfather Gianni Agnelli had given him a vicarious education by including him silently on business calls. Elkann helped pick the controversial outsider Sergio Marchionne, who won about $2 billion from General Motors to cancel a put option on Fiat's auto business and pushed industry consolidation, which led to Stellantis, now roughly 10% of Exor's assets.
The range is wide. Three of the four largest listed holdings have left since 2009. The PartnerRe purchase in 2015 ended with a sale to Covéa at an estimated 9 to 10 percent IRR, and the discussion of reinsurance as a poor fit for public markets is contested. Ferrari grew from about 15% of the portfolio to almost half, and whether the market sees it as luxury rather than a car maker is also disputed. February's roughly $3 billion Ferrari sale to fund buybacks is read as both a concentration signal and a verdict on Exor's own stock. Other threads include IVECO's defense separation, Lingotto's $6.4 billion asset management platform, and a bear case on health tech.
The NAV discount of 50 to 60 percent anchors the argument. About 70% of assets are listed, so the sum of the parts is easy to mark. Krishna argues that the market, not management, sets the discount. Against it he sets Exor's debt discipline of 10 to 20 percent of assets in long-dated bonds, and Agnelli's three stages of strength, privilege and vanity.
Exor is a Dutch-domiciled Agnelli family holding company whose persistent NAV discount reflects doubts about whether a holding company can keep compounding NAV per share once Ferrari's share of value grows, and Krishna argues that disciplined capital allocation and decisive leadership under John Elkann justify a long-horizon bet on management.
- Ferrari has driven nearly all recent NAV-per-share growth, and removing it leaves a collection of cyclical turnarounds
- A conservative balance sheet (debt at 10-20% of assets, long-duration bonds) lets Exor buy back stock at steep NAV discounts and avoid creditor pressure
- Elkann's track record of replacing underperforming CEOs and reshaping the portfolio shows a willingness to change course
Holding-company structure and market doubt keep Exor's NAV discount wide, beyond management's control.
- Exor was formed in 2009 to simplify a complex family ownership structure; it merged the older holding companies IFI (set up in 1927) and IFIL under one umbrella and later moved its legal headquarters and listing to the Netherlands.
“Exor of today was set up much, much later in the story, in 2009, and the reason was to simplify how the family's assets were managed, because before that it was a complex mess.”
- Exor moved its legal headquarters and listing to the Netherlands because the country gives full exemption on capital gains and dividends, a competitive tax rate, and extensive global tax treaties, making it a sensible base for a global holding company.
“You get full exemption on capital gains and dividends, a very competitive tax rate, extensive tax treaties globally. So it made sense for a global company to be based in the Netherlands.”
- Exor is a Dutch holding company controlled by the Agnelli family, but its history is essentially the history of Fiat and Italian industry, which makes its story intimately tied to twentieth-century Italian manufacturing.
“As you mentioned, Exor is a Dutch company on paper, but in its bones it's all Italian. It's really the history of Fiat, so it's intimately tied with the history of industry in Italy.”
- Exor's stock trades at a discount to its estimated spot NAV of roughly 50 to 60 percent, depending on assumptions, and the valuation is simple to compute because about 70% of assets are listed and can be marked to market.
“the stock trades at a big discount to this NAV, anywhere from 50 to 60% depending on your assumptions”
- A NAV discount is a normal feature of holding companies, but Exor's has been unusually high for a long time because a holding company is the opposite of a pure-play exceptional business, and since the discount is set by the market, investors should not expect management to close it.
“You shouldn't be in it hoping for a narrowing of the discount because that is not in management's control.”
- Juventus is a small, legacy holding kept because of family passion rather than economic logic; it is a tiny part of asset value and governance scandals, including the resignation of the entire board and the president, who was an Agnelli, make it a distraction from NAV per share growth.
“And the only possible reason it's in the portfolio is because it's a family passion. So it is what it is.”
- The market's persistent discount reflects doubt that Exor can keep compounding NAV per share, since recent growth has come almost entirely from Ferrari and the remaining assets are turnarounds in cyclical and structurally challenged markets run by a third party with a long time horizon.
“The NAV growth at Exor in the last three, four years, even longer, has all come from Ferrari. If you remove Ferrari, this ends up being an odd collection of turnarounds”
- About 70% of Exor's gross asset value, roughly 45 billion euros, is in listed stakes, and 70% of that is concentrated in four companies: Ferrari, Stellantis, CNH Industrial, and Philips.
“It's weighted very much towards the publics—70% of gross asset value. And gross asset value is roughly, let's say, 45 billion euros. 70% of that is in four companies”
- Investors in Exor need a long time horizon and must believe Elkann is aligned with minority shareholders, because the discount narrowing is outside management's control and returns should come from NAV per share growth.
“You shouldn't be in it hoping for a narrowing of the discount because that is not in management's control.”
- Exor's stock trades at a 50-60% discount to its spot NAV depending on assumptions, which is unusually high and has persisted for a very long period.
“the stock trades at a big discount to this NAV, anywhere from 50 to 60% depending on your assumptions”
- The market rewards companies doing unique things and excelling at them, as with Ferrari and Hermès, but a diversified holding company is the opposite of that kind of pure-play exceptional business.
“The market, of course, loves companies that are doing unique things and are exceptional at them. Ferrari, of course, Hermès would be another example.”
- Discount narrowing is not within management's control, so Exor's priority should be NAV per share growth rather than the discount, and the discount should be treated as a capital allocation opportunity.
“You shouldn't be in it hoping for a narrowing of the discount because that is not in management's control.”
- Exor's NAV growth over the last three to four years, and even longer, has come entirely from Ferrari, so removing Ferrari leaves little growth engine.
“It continues to be the big driver of NAV per share growth for Exor. ... I think it started at 15% and went as high as almost half the portfolio.”
Ferrari has driven Exor's NAV per share growth, with its portfolio weight actively managed.
- Ferrari is Exor's largest asset and the main driver of NAV per share growth; its value unlock since listing has been large, and Ferrari's share of the portfolio rose from about 15% to almost half of the portfolio.
“It continues to be the big driver of NAV per share growth for Exor. ... I think it started at 15% and went as high as almost half the portfolio.”
- The market treats Ferrari as an ultra-premium luxury company rather than a car maker because its ethos centers on motor racing and selling cars is almost an afterthought, and an EV transition will repeatedly test that classification.
“The ethos of Ferrari is motor racing and selling cars is almost an afterthought. That's what makes them unique.”
- In February Exor sold about $3 billion of Ferrari shares to fund buybacks and new investments, signaling both that Ferrari had become over-concentrated and that management viewed its own stock as deeply undervalued.
“In February, Exor sold about $3 billion worth of shares with the intent of using the proceeds towards both buybacks and additional investments.”
- Exor is comfortable with a single position concentration of roughly 25 to 30 percent of the portfolio, and Ferrari had grown well beyond that level, which is why management trimmed it.
“They like concentrated, but I think they're comfortable with a concentration level of 25 to 30% and Ferrari had grown much beyond that.”
Decisive action backed by financial discipline lets Exor exploit discounts and avoid inaction.
- Elkann is pragmatic about the discount, treating it as an opportunity for Exor to invest in itself; the decision to trim Ferrari and buy back stock was excellent because buybacks occurred at very steep discounts to NAV.
“The decision this year to trim Ferrari to buy back stock raised some eyebrows but was an excellent one in this context because it allowed them to buy back stock at very steep discounts to NAV.”
- The main lesson from Exor is decisiveness: when a decision is required, make it, and if it proves wrong, fix it, avoiding the 'thumb sucking' of hesitation and endless deliberation that Buffett describes.
“The one clear lesson that stands out is decisiveness. When you have to make a decision, make a decision. If it turns out to be wrong, fix it.”
- Exor values a stable dividend and the ability to act opportunistically more than trying to optimize its debt level, which Krishna argues is the only way to manage a family fortune for the very long term.
“I think they value that way more than trying to, quote unquote, optimize their debt level.”
- Gianni Agnelli observed that groups like Exor typically pass through three stages (strength, privilege and vanity), and Elkann quotes this to argue that only the first stage, strength, matters, meaning investment in change must be paired with preserved financial strength.
“Groups like ours typically go through three stages in their development. A time of strength, a time of privilege and a time of vanity. For me, the first is the only one that counts.”
- Elkann's early experience, which included needing to find Marchionne as CEO on about the fourth or fifth attempt within two years, taught him that sticking with the status quo would have meant the company did not survive, and this shaped his decisiveness.
“What he learned was if they had stuck with the status quo, they would not have survived. I think that makes Elkann decisive, willing to change.”
- Exor has never compromised on financial discipline: it keeps debt between 10 and 20 percent of the asset base, mostly long-duration bonds with little bank debt and maturities of five to six years, which keeps it from being at creditors' mercy and lets it sustain dividends and invest or buy back shares when opportunities arise.
“keep debt between 10, 20% of the asset base and increasingly keep the mix simple as well. You know, mostly bonds, very little bank debt, well spread out long duration, five to six years.”
- Long-term investors tend to have a bias toward no action, hiding behind a long time horizon to avoid uncertainty and sitting on past decisions, when they should periodically revisit whether those decisions still fit a changed environment.
“Long-term investors tend to have a bias to no action, sitting on past decisions in the name of long term and patient.”
Exor's value rests on leadership-driven optionality from private holdings, ventures, and timed investments.
- Exor defines its purpose as building great companies with great people, measures success by per-share NAV growth benchmarked against the MSCI World index, and frames the approach as a duality of entrepreneurial spirit and financial discipline.
“they define their purpose as building great companies with great people ... And they measure their success with a very clear metric, per share growth in NAV and benchmark it against the MSCI World benchmark”
- Exor's private portfolio (the Economist, Institut Mérieux, Louboutin, Welltec and Lingotto) is valued at face value, which is not significant today, but the optionality embedded in these assets could become meaningful over time.
“They're valued at face value, which isn't significant, but it could be.”
- Lingotto, Exor's asset management platform started in 2023, operates independently of Exor with about $6.4 billion in assets across long-short, public equities, fund-of-funds and direct private strategies, with the aim of building a wealth management platform.
“They also started an asset management platform in 2023. ... It has about 6.4 billion in assets across a range of strategies.”
- Because a holding company with an opportunistic leader is hard to forecast beyond five years, buying a collection of global assets at a huge discount is best understood as a bet on the leadership rather than on the current asset set.
“I think it's definitely a bet on the jockey more than just on the current set of assets.”
- Beyond the financial return on PartnerRe, Exor gained talent from PartnerRe and Covéa and a longer-term partnership with Covéa that helped launch its asset management business.
“Beyond just the financials, they actually brought in some strong talent from PartnerRe and from Covéa. Also a more long term partnership with Covéa to launch their asset management firm.”
- Exor bought a larger stake in The Economist from Pearson in 2015 and became its largest single shareholder, despite a difficult media business facing AI disruption, because the brand offers optionality and a sense of public service.
“Exor is the largest single shareholder there. They used to own a small 5% stake historically and in 2015 they bought a larger stake from Pearson and became the largest single shareholder.”
- Exor invested in Via, an urban mobility company optimizing shared passenger pooling for vehicle fleets, in 2020, owns about 9 percent, and recently filed a confidential S-1/A for an IPO, an early success for its ventures business.
“one of their investments through ventures is a company called Via. ... Exor invested in 2020; they own about 9%. Just recently they have filed an S-1/A confidential filing for an IPO.”
- Exor made its Welltec investment, a Danish robotics and tools company serving oil and gas wells, in 2016 when the energy complex was under stress, timing the investment almost perfectly.
“Very unique investment and Exor was able to time that investment almost perfectly. In 2016 when the entire energy complex was under stress, they were able to make a partnership with Welltec.”
- John Elkann joined the board of Meta earlier in the year, giving Exor a ringside view of AI and access to the Silicon Valley early-stage network.
“earlier this year John Elkann joined the board of Meta, which at the very least gives him a ringside view to AI.”
Fiat's industrial legacy, Marchionne's turnaround, and Elkann's succession shaped Exor's discipline and stewardship.
- After Marchionne took control of the car business, cut costs, and the family injected capital to renegotiate bank debt, Fiat moved from the brink of disaster to a position by the financial crisis where it could merge with Chrysler.
“The family also had to put in capital to renegotiate bank debt. And from the brink of disaster, they turn it around. By the time the financial crisis hits, Fiat is in a position to not just survive, but actually merge with Chrysler.”
- When John Elkann became the sole family representative at Fiat around age 27, after his grandfather and great-uncle died in 2003 and 2004, the company was struggling financially and operationally, had gone through four CEOs in three years, and looked as though it might not survive.
“So at the ripe age of 27, he becomes the sole family representative at the firm. And at that time, both financially and operationally, the company was struggling. They've been through four CEOs in three years”
- Marchionne secured about $2 billion from General Motors to cancel a put option Fiat held on its auto business, at a time when GM did not want to take on a struggling Fiat auto unit.
“First, he manages to get about $2 billion from General Motors to get rid of a put option that Fiat had with them on Fiat's auto business.”
- Gianni Agnelli gave his grandson John Elkann a vicarious education in the business from 1997 by including him as a silent participant in business calls and later reviewing the discussions with him.
“since 1997 his grandfather had gone out of the way to include him as a silent participant in a lot of business phone calls, later reviewing what was said, etc., to give him a vicarious sense of the business.”
- Marchionne argued the auto industry was over-capitalized, and reducing that excess capacity through industry consolidation was one of Fiat's major themes, which led directly to the Stellantis merger.
“Marchionne, in a very famous presentation a long time ago, talked about essentially the over-capitalization of the auto industry. And one of the biggest themes for Fiat was to reduce that by consolidation in the industry.”
- Elkann played a role in selecting Sergio Marchionne as Fiat CEO, an outsider who was controversial at the time but who had previously turned around SGS for the family; the choice proved to be a brilliant decision that transformed Fiat.
“One of the first things he does when he takes over was play a role in the selection of Sergio Marchionne as CEO of Fiat. This was very controversial at the time because Marchionne was an outsider, but it ended up being a brilliant decision.”
- Fiat was the industrial engine of Italy across the twentieth century, supplying the war effort in WWI, holding about 80% of the Italian auto market, and driving postwar reconstruction.
“Throughout the 20th century, Fiat was the industrial engine of the country... 80% of the Italian auto market was Fiat.”
- Exor's history is best understood through three leaders: Giovanni Agnelli the founder, who ran Fiat into a large conglomerate and sat as an Italian senator for over two decades; Gianni Agnelli, who ran the group for almost 40 years and formed the Ferrari partnership; and John Elkann, who leads today.
“you can actually look at the history of this company through three leaders who all have had an outsized impact on the group”
- Exor's financial discipline comes from the early Elkann years, when the family had to inject more capital to save Fiat from going under, and it has been the one core tenet never compromised for twenty years.
“That is the one core tenet they have never compromised on in the last 20 years. And it very much comes from the initial days of Elkann”
Exor continuously reshapes its portfolio, exiting holdings such as PartnerRe when conditions favor it.
- Exor bought the reinsurer PartnerRe in 2015 for about a $9 billion purchase price, owned it for five to six years, and sold it to Covéa for an estimated IRR of around 9 to 10 percent, with cat losses and high reinsurance multiples prompting the exit.
“PartnerRe was a reinsurance company that Exor bought back in 2015. They owned it for about five or six years before selling it. ... I think the IRR came out to maybe around 9, 10%. It was also decent sized, 9 billion purchase price.”
- Reinsurance is a business of taking volatility from others, and because public markets dislike volatility, a publicly traded reinsurer is structurally disadvantaged compared with a home for patient capital such as a family holding company, a model Berkshire Hathaway has shown can work.
“Reinsurance at its core is about taking volatility from others. That's the whole business model. But here's the thing. Markets hate volatility.”
- Exor is a continuously evolving holding company, so the Exor of 2035 will look nothing like the Exor of today, and that makes it worth following.
“It's a holding company. It's always changing... the Exor of 2035 is not going to look anything like the Exor of today”
- Since 2009, three of the four largest listed holdings have left the portfolio, which shows how much the group has been reshaped over fifteen years.
“In 2009, three of the big four are no longer in the portfolio. So that tells you the extent of change.”
- Exor changes its asset mix continuously and slowly, with measured change and constant refresh, and Elkann emphasizes ongoing renewal in every investor interaction.
“that means change is slow, measured, but there is constant refresh and renewal”
- Louboutin sought out Exor as a patient owner rather than joining a large luxury group, which is how Exor found the asset in a space where high-end luxury assets are scarce and in demand.
“They were able to find Louboutin because Louboutin was looking to be part of a more patient owner like Exor rather than be part of a large luxury group.”
- Exor sold PartnerRe to Covéa when reinsurance multiples were high and the offer was solid, illustrating a willingness to take a win and move on even though the original plan was long-term holding.
“So they decided, all right, let's take the win and move on.”
Healthcare, especially health technology, is Exor's most promising focus, and the Philips stake fits it.
- Exor has named healthcare, luxury and technology as its three very-long-term focus sectors, but luxury offers little to do because the high-end space is small, crowded and rarely offers independent assets at the right price.
“There are three sectors that they've highlighted as for the very long term. Where they want to be, healthcare, luxury and technology.”
- Exor started with a 17 to 18 percent stake in Philips and has increased it to almost 20 percent with board presence, giving it the ability to provide the stable ownership the company needs for a long-term turnaround.
“I think they started with a 17, 18% stake and now increased to almost 20% board presence.”
- The bear case for health tech is that innovation takes much longer than people expect, and companies often do not get paid for innovation because of regulation, so the payoff can be delayed well beyond investor horizons.
“In healthcare, innovation takes much longer than people expect, and very often companies don't get paid for innovation because of regulation.”
- Among its three long-duration focus sectors (healthcare, luxury and technology), healthcare technology, including imaging, diagnostics and genomics services, is where Exor is most likely to build expertise and make further investments, and within five years Exor could be a legitimate player there.
“healthcare technology is probably where they're likely to spend, build more expertise and more investments. ... In five years, Exor could be a legitimate player in health tech.”
- Institut Mérieux, a family-owned healthcare company spanning diagnostics, vaccines, immunotherapy, food safety and nutrition, is a recent investment that gives Exor a first step into health care and shares its family-ownership culture.
“It's really a first step for Exor into this world. Along with the investment in Philips, there's a lot of match with the family old culture with the Mérieux family.”
- Philips has gone from a mix of consumer electronics, lighting and semiconductors into a pure-play global health technology company, a restructuring that resonates with Fiat's own transformation, and it is facing difficult end markets and a sleep apnea device recall.
“The last decade or so at Philips has a lot of resonance with their own restructuring of Fiat. Philips went from a mix of everything—consumer electronics, lighting, semiconductors—to a pure play global health tech company.”
Remaining holdings are undervalued cyclical turnarounds in challenged end markets.
- CNH Industrial holds the more stable agricultural equipment business, which is less cyclical and higher quality than IVECO's trucks, and is the number two global player behind John Deere; it is in a cyclical low but its valuation is not demanding.
“And the Ag equipment business, which is a more higher quality, less cyclical business, became CNHI. They are the number two global player in that space after John Deere.”
- Stellantis, formed from the Fiat Chrysler and Peugeot mega-merger, is clearly a car company with a difficult business, facing overcapacity and EV transition costs, and it trades at an undemanding valuation; it accounts for roughly 10% of Exor's assets.
“With Stellantis, it is the product of a mega merger between Fiat Chrysler and Peugeot. ... It is definitely a car company, there's no question about that.”
- IVECO, spun off in 2022, is trying to separate its defense business through a spinoff or sale, and strong pent-up demand for defense assets may help; there is also M&A chatter about the core truck business including possible talks with Tata Motors.
“The interesting thing is they're trying to separate out the defense business as a spinoff or a sale. And as you can imagine right now there is a lot of pent-up demand for anything in the defense sector.”
- Stellantis, CNH Industrial and IVECO are all cyclical, capital-intensive businesses in some phase of turnaround with challenged end markets, and aside from Ferrari none of the listed companies looks overly valued, so the portfolio is buying fairly undervalued assets.
“in the underlying NAV, with the exception of Ferrari, I wouldn't call any of the other listed companies as overly valued.”
- Clarivate, an analytics and subscription data company spun off from Thomson Reuters, serves as one of the building blocks for Exor's planned move into health technology alongside Philips and Institut Mérieux, even though it has significantly underperformed as a listed company.
“Clarivate not only is an interesting investment in itself, but it provides one of the building blocks, I think, for them in that ecosystem where they want to step into the future.”
Exor's leadership picks capable insiders or outsiders and oversees them as a critical friend.
- After finding the right leader, Exor acts as a critical friend rather than an aggressive owner: it reviews plans and organizational structures but lets leaders execute, and it is open to both insider and outsider CEOs.
“once they find a good leader, they view their own role more like a critical friend rather than an aggressive owner. They will come in, look at plans, look at the Orgs, but let the leaders execute.”
- Benedetto Vigna, a strong technical leader with many patents in sensors and microelectronics and no auto background, was chosen as Ferrari's CEO to lead the company into the EV transition.
“Benedetto Vigna at Ferrari was an outsider. ... Very strong technical leader, many patents in sensors and microelectronics. He seemed a very inspired choice, again, not auto, to lead Ferrari into the EV world.”
- Marchionne served as Elkann's personal mentor and transformative figure, and Elkann still publicly credits him, which shaped Elkann's leadership style.
“Even today, Elkann, every opportunity he gets, he pays homage to Sergio as both a personal mentor and a transformative figure in his life.”
- Elkann's global background, including birth in New York, schooling in the UK, Brazil, and France, engineering school in Turin, and a stint at GE, gave him a multilingual, international profile that suited the global group he inherited.
“He had almost the perfect background for what this group needed. Very global mindset.”
- Sergio Marchionne is described as one of the greatest CEOs ever, an outsider whose success shaped Exor's openness to both insiders and outsiders in leadership appointments.
“The greatest success again, Sergio Marchionne was one of the greatest CEOs ever. He was an outside CEO”